Cardiac troponin assay method and assay reagent

    公开(公告)号:US11802867B2

    公开(公告)日:2023-10-31

    申请号:US16332647

    申请日:2017-09-12

    申请人: FUJIREBIO INC.

    IPC分类号: G01N33/53 G01N33/68

    CPC分类号: G01N33/5306 G01N33/6887

    摘要: A measurement method and a measurement reagent for cardiac troponin which enable accurate measurement of the amount of cardiac troponin contained in a sample irrespective of the type of the sample and the presence or absence of other components are disclosed. The measurement method for cardiac troponin, wherein cardiac troponin in a sample separated from a body is measured by an immunoassay, includes a pretreatment step of mixing the sample separated from a body with a pretreatment liquid containing one or both of a surfactant and an acidifier. The reagent for immunoassay of cardiac troponin includes a pretreatment liquid containing one or both of a surfactant and an acidifier.

    Method and reagent for measuring thyroglobulin

    公开(公告)号:US11768209B2

    公开(公告)日:2023-09-26

    申请号:US16330549

    申请日:2017-09-05

    申请人: FUJIREBIO INC.

    IPC分类号: G01N33/78

    CPC分类号: G01N33/78

    摘要: A measurement method and a measurement reagent for thyroglobulin, which enable measurement of a more accurate amount of thyroglobulin by a single test without being influenced by interference of anti-thyroglobulin antibody, are disclosed. The measurement method for thyroglobulin, wherein thyroglobulin in a sample separated from a body is measured by an immunoassay, includes a pretreatment step of mixing the sample separated from a body with a pretreatment liquid containing one or both of a surfactant and an acidifier. The reagent for immunoassay of thyroglobulin includes a pretreatment liquid containing one or both of a surfactant and an acidifier.

    Kit and method for measuring prostaglandin E-major urinary metabolite

    公开(公告)号:US11169162B2

    公开(公告)日:2021-11-09

    申请号:US16084634

    申请日:2017-03-13

    申请人: FUJIREBIO INC.

    IPC分类号: G01N33/88 G01N33/543

    摘要: Disclosed is a method of measuring the prostaglandin E main urinary metabolite (PGE-MUM), in which a mixture solution of a urine sample treated with alkali can directly be subjected to an antigen-antibody reaction system in an immunoassay of PGE-MUM, without neutralization and dilution followed by dispensation. The method of measuring PGE-MUM includes the steps of: a) mixing a urine sample with an alkaline aqueous solution, and b) subjecting the mixture solution resulting from a) to an immunoassay using a bicyclo PGE-MUM-immobilized or anti-bicyclo PGE-MUM antibody-immobilized solid phase to measure PGE-MUM in the urine sample, wherein the immunoassay is performed in a weakly-acidic basal buffer solution in the presence of a second pH buffering agent which exerts a buffering effect in the basic range and is different from the pH buffering agent contained in the basal buffer solution, and in the presence of a cationic surfactant.

    Assay method and assay kit for hepatitis B virus S antigen

    公开(公告)号:US11454632B2

    公开(公告)日:2022-09-27

    申请号:US16768419

    申请日:2018-11-22

    申请人: FUJIREBIO INC.

    摘要: Disclosed is a highly sensitive assay method and assay kit for HBsAg, which do not require treatment with a strong acid or alkali in the sample pretreatment, and which is less susceptible to influences by the autoantibodies. The assay method for hepatitis B virus s antigen in a sample separated from a living body includes: a pretreatment step of mixing a sample with a pretreatment reagent containing a reducing agent, to reduce hepatitis B virus s antigen; and an immunoassay step of subjecting the pretreated sample to an immunoassay of hepatitis B virus s antigen using at least one antibody or antigen-binding fragment thereof capable of antigen-antibody reaction with a reduced peptide composed of the amino acids at positions 98 to 179 of hepatitis B virus s antigen.